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Neurotransmitter release 
Received 9 May 1990 
Axon terminals release more than one physiologically active substance. Synaptic messengers may be stored in two different types of vesicles. Small 
electron-lucent vesicles mainly store classical low molecular weight transmitter substances and the larger electron-dense granules store and release 
proteins and peptides. Release of the two types of substances underlies different physiological control. Release of messenger molecules from axon 
terminals is triggered by influx of Ca’+ through voltage sensitive CT+ channels and a rise in cytosolic Cal- concentrations. Neither the i~lrnediate 
Ca” target(s) nor the molecular species involved in synaptic vesicle docking, fusion and retrieval are known. It is. however, hkely that steps involved 
in the molecular cascade of transmitter release include liberation of vesicles from their association with the cytonet and phosphorylatlotl hy protein 
kinasc C of proteins which have the ability to alter between membrane bound and cytoplasmic forms and thus facilitate or initiate the molecular 
interaction between synaptic vesicles and the plasma membrane. 
Exocytosis; Neurotransmitter; Protein kinase C; Release: Synapse; Vesicle 
1. SITE AND CELLULAR SOURCE OF 
NEUROTRANS~ITTER RELEASE 
I. 1. Types 0s refease and types of released messengers 
Upon arrival of an action potential the phasic release 
of a quantity of neurotransmitt~r is evoked from the 
terminal axon segment. This is the general physico- 
chemical mechanism underlying the fast processing of 
information between nerve cells and also the transfer of 
signals from nerve to muscles and glands. 
It is likely that all neurons release at their axon ter- 
minals more than one physiologically active substance. 
In addition to the classical low molecular weight 
messenger molecules like acetylcholine, noradrenaline 
and various ammo acids also proteins and peptides are 
secreted [1,2]. This observation has abolished the 
former one-neuron-one-transmitter doctrine. Whether 
the substances coreleased with the classical transmitter 
substances serve as cotransmitters sustaining signal 
transfer or rather as modulators of the synaptic signal 
or even act at non-synaptic sites has to be discussed 
together with the classical transmitter regarding both 
the cellular preconditions and the molecular cascade of 
neurotransmitt~r release. 
As has been shown for a variety of neurotransmitter 
substances, classical neurotransmitters are released in 
the form of small quanta1 packages and this is thought 
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to be the result of the exocytotic secretion of the con- 
tents of individual synaptic vesicles. In addition to this 
phasic release mechanism there is a small but con- 
tinuous release of neurotra~~sI~itter from nerve ter- 
minals which has also been referred to as transmitter 
leakage [3-61. 
I .2. Consensw for exocyrosis 
Exocytosis of neurotransmitter involves the release of 
soluble synaptic vesicle contents after controlled fusion 
with the presynaptic plasma membrane. Support for 
this view comes from ultrastructurai analyses of nerve 
terminals on induced transmitter release, uptake of ex- 
tracellular markers into synaptic vesicles, im- 
munocytochemicai analyses, the comparison of synap- 
tic vesicle contents and products released, biochemical 
studies of synaptic vesicle life cycle and synaptic vesicle 
heterogeneity, and the quanta] nature of the postsynap- 
tic signal [6-131. 
Using rapid freezing techniques it could be 
demonstrated at the frog neuromuscular junction that 
the exocytotic fusion of chofinergic synaptic vesicles oc- 
curs about 0.5 ms before the onset of the postsynaptic 
signal. When the synapse is intensely activated and 
synaptic vesicle recycling is impaired, the loss in synap- 
tic vesicle numbers can be related directly to the counts 
of postsynaptically recorded transmitter quanta. If 
synaptic vesicle recycling is completely blocked, the in- 
corporation of the synaptic vesicle membrane compart- 
ment into the presynaptic plasma membrane can be 
visualized by immunocytochen~ical methods using an- 
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tibodies against synaptic vesicle membrane proteins 
fl2f. Whereas it had been assumed for a long time that 
a singie synaptic vesicle gives rise to a postsynaptic 
quantum, the observation at the neuromuscular junc- 
tion that the classical quanta1 event may in fact consist 
of subquanta has come as a challenge to the original 
vesicle hypothesis (14,15]. Does one quantum corres- 
pond to the release of the contents of a single or of 
several synaptic vesicles? Are synaptic vesicles func- 
tionally heterogeneous with different release pro- 
babilities for different vesicle pools f3,73? 
For the neurotransmitter acetylcholine it has also 
been suggested [ 161 that it is not released by exocytosis 
of synaptic vesicles but through pores in the presynapti~ 
plasma membrane which are formed by the association 
of membrane proteins referred to as mediatophore. The 
Ca2 + -activated opening of a mediatophore complex 
wouId give rise to the release of a quantum of 
acetylcholine. Similarly, the evoked release of amino 
acid transmitters from cytoplasmic rather than from 
synaptic vesicle stores has long been inferred. The pro- 
tein subunit of the mediatophore complex has now been 
identified as a component of the synaptic vesicle proton 
pumping ATPase [ 171. From studies on the vesicular 
uptake and storage of amino acids [lS] and on the Ca2 * 
dependency of amino acid release from brain synap- 
tosomes [5] strong evidence could be derived for ex- 
ocytotic release of amino acid transmitters. 
1.3. Non-neuronal model systems 
Thus, the basic mechanism of evoked neurotransmit- 
ter release is analogous or perhaps identical to controfl- 
ed secretory release from other secretory systems in- 
cluding endocrine and exocrine gland cells and possibly 
also mast cells, neutrophils or even oocytes or 
Paramaecium. There has been an increasing interest in 
non-neuronal model systems for studying the molecular 
mechanism underlying exocytosis in general but also to 
understand more fully neuronal secretion mechanisms 
[19]. Immediate access to the exocytotic release 
mechanism of these cells could be obtained by elec- 
tropermeabilization [20], by permeabilization with 
digitonin and more recently with bacterial exotoxins 
121-231 or with the patch clamp technique f24,25]. 
2. MORE THAN ONE TYPE OF VESICLE AND 
MORE THAN ONE TYPE OF EXOCYTOTfC 
CONTROL? 
Before discussing some of the key mechanisms in- 
volved in exocytosis, a number of basic features of the 
neuronal secretory machinery have to be evaluated. 
This is important if it comes to a comparison with other 
secretory systems and the deduction of consensus 
mechanisms. 
Neurons possess in their axons two principal struc- 
tural types of secretory vesicles: the larger electron- 
dense or dense-cored vesicles (also referred to as 
granuIes) which store a variety of proteins and peptides 
and possibiy also smaller molecular weight 
neurotransmitters. The function of these granules is 
thought to be mainly in the release of neuropeptides. 
The smaller electron-lucent vesicles do not store pro- 
teins and their function is in the rapid release of low 
molecular weight messengers. Both types reiease their 
contents by controlled exocytosis. This means, that ax- 
on terminals possess a differential organelle outfit for 
the release of high and low molecular weight 
substances. The two types of cell organelles differ not 
only with regard to their contents. At present there is 
some debate as to what extent they carry common mem- 
brane proteins. Whereas there are common features like 
the presence of a proton pumping ATPase [26], the 
presence of other common components is interpreted 
differently whether biochemical or ultrastructural 
evidence is used as the main argument [10,27-291. A 
possible reason for some of the djs~repan~y may come 
from difficulties in comparing the adrenergic vesicle 
types ‘large-dense cored’, ‘small dense-cored’ and in 
addition ‘electron-~u~ent~ to the two principal vesicle 
types of other neurons. 
It is, however, clear that the release characteristics of 
low and high nloIe~ular weight messengers differ with 
regard to both the activation pattern of the axon and 
the Ca2 * dependency ]6,30]: at low action potential fre- 
quencies release of low molecular weight messengers 
(classical transmitters) predominates whereas release of 
peptides depends on higher frequencies. Furthermore, 
differential Ca2+ channels appear to be involved in trig- 
gering exocytosis from the two organellar sources [3 11. 
This is paralleled by the observation that the small 
electron-lucent vesicles release their contents at mor- 
phologically specified release sites of the presynaptic 
membrane whereas the larger peptide-loaded granules 
release their contents distal to the synaptic cleft [32]. 
Furthermore, the association with surface proteins for 
the linkage to the cytonet is different between granules 
and smaller vesicles. Synapsin 1 which is thought to con- 
nect electron-lucent synaptic vesicles to actin and 
tubulin filaments [34] and which is involved in the con- 
trol of neurotransnlitter elease ]35] is not associated 
with the membrane of protein-storing secretory 
granules [36]. All these observations uggest hat there 
are differences in the cellular and molecular precondi- 
tions for the release of low and high molecular weight 
messengers and thus for granules and small electron- 
fucent vesicles. Whether there are also differences in the 
final pathway of the exocytotic fusion event needs to be 
elucidated. 
ft has also been suggested that neurons contain only 
one principal type of vesicle, the dense-cored granule. 
After release of its peptide and protein contents and 
local membrane recycling this would turn into a smaller 
eiectron-lucent vesicle to be used in further cycles of 
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release and reloading of small messengers 1371. This 
would, however, need to involve also alterations in the 
membrane properties of the organelfe. It is of interest 
that the small electron-lu~ent vesicle type has now been 
identified as a separate organelle also in neurosecretory 
axon terminals using vesicIe-specific antibodies [36] and 
in non-neuronal cells in tissue culture transfected with a 
gene coding for a synaptic vesicle-specific protein 
[38,39]. Thus, large dense-cored granules and small 
electron-lucent vesicles may represent different vehicles 
for exocytotic release in a variety of cellular systems. 
3. THE MOLECULAR CASCADE UNDERLYING 
EXOCYTOSIS 
Due to the inaccessibility of the terminal axon seg- 
ment and the small size of isolated synaptosomes, infor- 
mation concerning the molecular mechanism of 
transmitter release has also been gained from studies of 
model systems like the adrenal medulla or neutrophils 
and mast cells. It has to be seen to what extent both the 
mechanisms regulating exocytosis and the molecular 
cascade of vesicle fusion and fission are identical in all 
of these secretory systems and even between the two 
principal synaptic vesicle types. 
The number of molecular events which are implicated 
in the mechanism of synaptic vesicle exocytosis is ex- 
panding rapidly. They include an increase in the 
cytosolic Ca2 + concentration into the micromolar 
range 140,411 or even higher 1311, Mg-ATP and the ac- 
tivation of protein kinases, in particular of protein 
kinase C [40,42-441, synaptic vesicle-associated pro- 
teins like synapsins I and II or a chromaffin granule- 
binding protein [45-471, the phosphoproteins B-50 
(GAP-43) [48] and P92 (possibly the MARCKS protein) 
[81> cytoskeletal proteins like actin and fodrin 
[23,50-543, GTP-binding proteins [55-591, arachidonic 
acid, and even others [24,60,61]. It is, however, not 
clear how these various molecular components interact 
and how their interaction is regulated. 
3.2. The senfral role of Ca2 + 
In action potential evoked synaptic transmission the 
elevation of the intracellular Ca2 ’ Ievel following Ca* +’ 
influx through voltage-gated Ca2 + channels is presum- 
ably the very first step of the cascade [4l]. In this 
respect the nerve terminal differs from non-neuronal 
secretory systems where exocytosis is initiated by the ac- 
tion of receptors at the cell membrane 162). However, it 
could be demonstrated that in a number of experimen- 
tal conditions neurotransmitter can also be released in 
the absence of extracellular Ca2 ’ [63,64]. There is even 
evidence that neurotransmitter released in the absence 
of Ca2+ may be derived from a different intracellular 
pool than that in the presence of Ca”’ j6.5). Together 
this documents the potential of intracellular Ca’” 
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stores in rnodulatir~g or - under certain experin~ental 
conditions - in sustaining axonal transmitter release. 
The concentration of Ca” + in the nerve terrn~i~al is con- 
trolled by a complex system of soluble buffers, 
organellar stores and membrane transport systems with 
varying Ca2+ transport affinities and capacities and 
every distortion will result in a modulation of transmit- 
ter release 166,671, Ca’ ’ is sequestered inside the nerve 
terminal in the smooth endoplasmic reticulum, synaptic 
vesicles, mito~hondr~a, and possibly also calcisomes. 
Furtllermor~, there exist intracellular buffering systems 
like Ca’ * -binding proteins [68,69]. Inositol 
polyphosphates have been assigned a key role in Ca’+ 
i~ltra~eIluIar homeostasis. lnositol 1,4,5-trispIlosphate 
is formed on receptor-mediated and G-protein- 
controlled turnover of j~hosphatidylirlositol 
4,5-bisphosphate together with diacylglycerol, an ac- 
tivator of protein kinase C. The inositol trisphosphate 
functions via specific receptors in the release of Ca”+ 
from intracellutar stores, presumably the en- 
doplasmatic reticulum and/or the calcisome [70]. In 
axon terminals receptor-mediated turnover of synaptic 
phosphoinositides for mobilizing Ca’+ from internal 
stores may serve mainly as a secondary and modulatory 
mechanism. It is a major disadvantage that we still do 
not know the immediate Ca’” target(s). 
3.3. Molecular cascade downstream of the CU’~ in_flux 
An early step in the initiation of vesicle exocytosis is 
presumably the mobilization of synaptic vesicles from 
their association with the cytonet [8,34] and possibIy 
the removal of a cytoskeletal undercoating of the 
presynaptic release site 1231. This may explain the in- 
volvement of synapsin I and various cytoskeletal pro- 
teins in the release process. Ca” and protein 
phosphorylation play a major role in the control of 
these processes [23,45,71]. Furthermore, protein kinase 
C-dependent protein phosph~rylation is likely to piay a 
key role in the initiation of the esocytotic event. There 
is strong evidence that activation of protein kinase C 
potentiates transmitter release 172-751. This enzyme is 
unique in that its soluble form is capable of being 
translocated to a membraI~e-bound form [76,77]. The 
endogenous activators of the enzyme are thought to be 
diacylglycerol and Ca’+ 1781. Two of its presynapti~ 
targets which are by now we11 defined are the B-SO pro- 
tein [79,X0] and the MARCUS protein ]81]. We still 
know, however, very little of how the substrate proteins 
for protein kinase C interpose betvveen synaptic vesicles 
and the presynaptic plasma metnbrane. A protein of Mr 
92 000 (P92, presumably identical with the MARCKS 
protein) associated with synaptic plasma membranes 
has been found to bind to synaptic vesicites after protein 
kinase C-dependent phosphorylation 18,821. It may 
thus act as a mediator for docking the synaptic vesicle 
to its release site. Other evidence demonstrates that an- 
tibodies against the B-50 protein introduced into brain 
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synaptosomes inhibit transmitter elease implicating the 
i~voIvement of this protein in exocytosis [48]. Similarly 
exocytosis is inhibi&!d by in~ra~~llul~ application of 
antibodies against the ~hromaffin-granule binding pro- 
tein f46]. 
Phosphor~lation of the ~euro~~spec~fic B-50 protein 
has been correlated to transmitter release, long-term 
potentiation and also neurite outgrowth [44,83,84f. The 
B-SO protein has been reported to bind to the inside of 
the plasma membrane [85] to the actin rich neuronal 
membrane skeleton [86] and also to ~aImod~lin [87f, 
Similarly the MARCKS protein, which is enriched in 
brain but can also be detected in a number of other 
tissues, becomes phosphorylated on induced transmit- 
ter release from synaptosomes and on activation of 
~hrornaff~n cells [74,88-901. Both the B-40 and the 
MARCUS protein are fatty-acylated [80,91], and in the 
fatty-acylated form they could be membrane anchored. 
Fatty-ac~rlatio~ and thus membrane anchoring may be 
regufated by protein kinase C-dependent phos~horyIa- 
tion [92,93]. However, additionat properties of the pro- 
tein may be essential for its targeting ta specific do- 
mains of the nerve cell membrane f94J. Regarding the 
strong evidence for protein phosp~oryIat~o~ in 
n~ur~trai~smitter exocytosis, the importance of 
de~hosphorylation events in this process cannot be 
overestimated f95,96]. 
When docking of synaptic vesicles is achieved, this 
step is followed by an as yet undefined mechanism of 
membrane fusion and fission. It is thought that the in- 
teraction of the two membrane compartments is in- 
itiated by a ~~an~~l-like structure possibly i~voIv~~~ 
corresponding protein channels in the synaptic vesicle 
~l~rnbran~ and the presynaptic plasma membrane 
[8,97,98]. Eventually soluble messengers may be releas- 
ed through a short-lived ‘fusion pore’ f24,991 and the 
synaptic vesicle membrane may be recycled for re-use 
[ lOtI]. From electrophysiological experiments it has 
been concIuded that only about 100-200 ps elapse be- 
tween the influx of Ca’ * and transmitter eiease riots. 
Thus, the process leading to the fusion of small 
eIectr~n~Iu~e~t synaptic vesicles must be very rapid. 
This may be another aspect where exoocytosis of larger 
granules and small synaptic vesicles differ. 
4. POPULATION OF TRA~S~~ITTER RELEASE 
Synaptic transmission modulates and is subject to 
r~oduIation. This is of great importance e.g. for synap- 
tic information processing and modulation processes 
involved in behav~oural plasticity phenomena. Reieas- 
ing nerve terminals possess receptors for other transmit- 
ter substances, and pra~ti~aIly alf neur~tra~sm~tt~r 
substances also act back to the terminals from which 
they were reIeased via presynapt.ic receptors ~autore~ep” 
tars). The modulation may involve receptor-mediated 
modifications of e.g, K + or Cazc channefs and thus 
control the availability of extraceIluIar Ca’; for 
transmitter elease. External messengers may, however, 
also act via receptor-~~ctiva~ed G-proteins controllirrg 
phosphoiipase C activity and thus the molecular 
cascade involved in vesicle exocytosis. This wouid result. 
in changes in the intraterminal Ca”; level, the concen- 
tration of dia~~lgI~~eroI for a~t~v~t~~~ of protein kinase 
C, and possibly other messenger systems f51 ,lOZ]. in 
order to fully understand the molecular cascade 
underlying exocytosis at rhe axon terminal it may thus 
be necessary to clearly differentiate between two events: 
the cascade following the arrival of the action potential 
and Ca’ + influx leading to exocytotic release on the one 
hand, and additional mechanisms which are involved in 
n~od~lating this event (e.g. by presynapt~~ receptor 
mediated ~~ecba~~srns~ and causing plasticity 
pllei~omena like potentiati~n or possibly also decrement 
on the other. Since secretion from model systems like 
mast cells or neutrophifs is activated under 
~~ysiologi~aI conditions by receptor-mediated 
mechanisms only (and not by action potentiaIs~, the 
sensitivity and preponderance of the molecular 
mechanisms involved in release may differ [l@&fOrl]. 
5. RESTING RE.LEASE 
At least for low molecular weight transmitter 
substances there is in addition to quanta1 also a non- 
quanta1 ~ra~smi~~~r release j4,5]. bin-quanta release is 
preponderant under resting conditions, independent of 
externaI Ca” + , and results in a steady molecular leakage 
of transmitter [I@]. Whereas quanta1 retease is poten- 
t&ted on depolarization of the axon terminxt this is not 
the case for non-quanta1 release. Neither the 
mechanism of this Ca’+ -independent leakage nor its 
p~~s~ologi~aI impIi~ations are clear. At the 
~e~romus~uIar junction it has been suggested to result 
from the transient incorporation of the vesicular 
acetylcholine transporter into the presynaptic plasma 
f~~e~lbrane o  vesiofe exocytosis [I&$ This would aflow 
the transmitter to leave the nerve terminal by a carrier- 
mediated mechanism and, accordingly, the released 
neur~tr~nsn~itter would be derived from a non-vesicIe 
bound, cytopfasmic poet. 
6. SYNOPSIS 
Whilst by now many of the prin~~p~I bnjld~~g-stones 
making up the molecular con&d mechanisms involved 
in neurotransmitter release are known, they still have to 
be placed into the right order _ The moIecuIar cascade of 
the exocytotic event at the nerve terminal remains an 
enigma. In particulars the Ca* + target(s) and the 
molecular (protein and/or lipid) components directly 
involved in synaptic vesicle dockjng, fusion and 
retrievat need co be identified. 
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